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Antimicrobial peptides are universal host defense membrane-targeting molecules in a variety of life forms. Structure elucidation provides
important insight into the mechanism of action. Here we present the three-dimensional structure of a membrane peptide in complex with
dioctanoyl phosphatidylglycerol (D8PG) micelles determined by solution NMR spectroscopy. The model peptide, derived from the key
antibacterial region of human LL-37, adopted an amphipathic helical structure based on 182 NOE-generated distance restraints and 34 chemical
shift-derived angle restraints. Using the same NOESY experiment, it is also possible to delineate in detail the location of this peptide in lipid
micelles via one-dimensional slice analysis of the intermolecular NOE cross peaks between the peptide and lipid. Hydrophobic aromatic side
chains gave medium to strong NOE cross peaks, backbone amide protons and interfacial arginine side chain HN protons showed weak cross peaks,
and arginine side chains on the hydrophilic face yielded no cross peaks with D8PG. Such a peptide–lipid intermolecular NOE pattern indicates a
surface location of the amphipathic helix on the lipid micelle. In contrast, the εHN protons of the three arginine side chains showed more or less
similar intermolecular NOE cross peaks with lipid acyl chains when the helical structure was disrupted by selective D-amino acid incorporation,
providing the basis for the selective toxic effect of the peptide against bacteria but not human cells. The differences in the intermolecular NOE
patterns indicate that these peptides interact with model membranes in different mechanisms. Major NMR experiments for detecting protein–lipid
NOE cross peaks are discussed.
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Because of the challenging nature, structural studies of
membrane proteins are in the frontier of modern structural
biology. Based on the mode of membrane association, these
proteins are classified into two broad families: peripheral and
integral. Peripheral membrane proteins bind to the surface of the
membranes, while integral membrane proteins must go through
the membranes. Antimicrobial peptides are ancient host defense
molecules in nearly all life forms [1–4]. More than 550 mature
peptides are collected in the antimicrobial peptide database [5].
Such peptides are believed to kill bacteria by targeting bacterial
membranes. These peptides may be located on the membrane
surface or transverse membranes. Because antimicrobial pep-
tides usually consist of less than 50 residues, they are regarded
Table 1
Primary structures of PepA and PepB
Peptide Amino acid sequence
PepA a GIKEFKRIVQRIKDFLRNLV-NH2
PepBb FKRIVQRIKDFLRNLV-NH2
a Corresponding to residues 13–32 of human LL-37 with the positions
between I13 and G14 swapped. NH2 means C-terminal amidation.
b Corresponding to residues 17–32 of human LL-37. D-amino acids are
underlined.
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both solution and solid-state NMR [6–10,52,53].
In humans, defensins and cathelicidins are the two major
families of antimicrobial peptides. While several cathelicidins
were found in animals such as sheep, cow, and pig, only one
cathelicidin peptide dubbed LL-37 was identified in humans
[11,12]. The importance of this host defense molecule to the
health of people is now well established. Patients lacking
this molecule are more susceptible to infections [13]. While
cathelicidin knockout mice are more readily infected [14],
expression of additional cathelicidins protects the animals from
infection [15]. LL-37 also protects rats from sepsis caused by
Gram-negative bacteria [16]. It is found that LL-37 is reduced in
cystic fibrosis (CF) airways as a result of direct interaction with
DNA and filamentous F-actin [17]. As a consequence, there is
high interest in developing peptide analogs of therapeutic
importance using human LL-37 as a template (reviewed in ref.
[18]). While other laboratories found different active regions
ranging from 20 to 24 residues [19–21], we identified a minimal
antibacterial peptide corresponding to residues 17–29 of LL-37
by utilizing the TOCSY-trim experiment [22]. This 13-residue
core peptide remains active after sequence reversal [23]. Of
outstanding interest is that the retro-core LL-37 peptide shows
sequence homology to aurein 1.2, a 13-residue antimicrobial
and anticancer peptide isolated in Australian Bell frogs [24].
According to motif search of the antimicrobial peptide database
[5], aurein 1.2 was found to also show sequence homology to an
essential bacterial membrane anchor of enzyme IIAGlc discov-
ered in Escherichia coli [25]. As the membrane anchor se-
quence is originated from E. coli, it is not surprising to see that
the synthetic peptide corresponding to the membrane anchor
sequence of the protein is not toxic to the bacterium itself. The
fact that this membrane anchor binds to anionic lipids but not
zwitterionic lipids suggests a minimal membrane-targeting
sequence [26]. Compared to the membrane anchor, the toxic
effect of aurein 1.2 is ascribed to a more hydrophobic and longer
amphipathic helix, because they have the identical number of
cationic lysines. In contrast, a higher antibacterial toxicity of the
retro-LL-37 core peptide, compared to the membrane anchor,
results from additional cationic residues, since the two peptides
have a similar hydrophobicity according to their retention times
on reverse-phase HPLC [23].
The effects of ions, pH, and peptide concentration on the
conformation of LL-37 were previously investigated by CD
studies. At a micromolar concentration in water, LL-37 was
disordered at an acidic pH but became helical with the increase in
pH or salts [54]. Oren et al. [55] found that LL-37 self-associated
when bound to zwitterionic lipids but disassociated into
monomers in the presence of negatively charged vesicles. For
structural studies of membrane-associated peptides, SDS was
widely used as a mimic of anionic membranes [6,10,46,51]. We
previously reported structural studies of LL-37 fragments
in SDS micelles. For a C-terminal fragment of LL-37 cor-
responding to residues 13–37, we found that only the middle
region was helical [22]. In this study, we report the three-
dimensional structure of an LL-37-derived model peptide
(pepA) in complex with D8PG. The rationale for the use ofD8PG as a bacterial membrane-mimetic model [27–29] is that a
significant population of phosphatidylglycerols (PGs) in bac-
terial membranes determines the selective targeting of many
cationic peptides [6–10]. Based on the C-terminal segment of
LL-37, pepAwas designed in two steps. First, the disordered C-
terminal region corresponding to residues 33–37 was removed.
Second, the order of I13G14 was changed to G13I14, since
many antimicrobial peptides are known to start with a glycine at
the N-terminus [30]. Antibacterial assays using E. coli K12
found that pepA had the same antibacterial activity as full-length
LL-37 (Minimal inhibition concentration 40 μM) [22]. Because
neither the sequence swap nor deletion had a clear effect on the
antimicrobial activity of the model peptide, pepA (sequence in
Table 1) may be regarded as a useful model for human LL-37.
To our knowledge, this is the first 3D structure reported for
an antimicrobial peptide in D8PG. More importantly, one-
dimensional peptide–lipid intermolecular NOE slice analysis
also allows for the mapping of the location of the model peptide
on the surface of the lipid micelle using the same NMR experi-
ment. As a comparison, we also report the intermolecular NOE
analysis of pepB, another LL-37-derived peptide with a mixture
of D- and L-amino acids (sequence in Table 1). The differences in
both structure and peptide–lipid NOE pattern suggest that pepA
and pepB may kill bacteria in different manners.
2. Materials and methods
2.1. Materials
Both pepA and pepB (N95% pure) were synthesized and purified by
Genemed Synthesis (San Francisco, CA). Protonated D8PG (N98%) was
purchased from Avanti Polar Lipids (Alabaster, AL). Chloroform was removed
from phospholipids under a stream of nitrogen gas followed by evaporation
under vacuum overnight. All chemicals were used without further purification.
2.2. NMR spectroscopy
The NMR samples were prepared by mixing the peptide with D8PG at a
molar ratio of 1:5 (2 mM peptide), containing 10% D2O as field-locking signal.
Such a ratio was found to be sufficient to stabilize the structure of the peptide.
The samples were not buffered. For optimal NMR spectra, the pH of each
sample was adjusted to the range of 5 to 6 by using microliter aliquots of HCl or
NaOH solution and measured directly in the 5-mm NMR tube with a micro-pH
electrode (Wilmad-Labglass). This is because a lower pH reduces the solubility
of D8PG; a higher pH increases the exchange between peptide and water, which
is unfavorable for the observation of intermolecular NOE cross peaks between
arginine side chains and D8PG (below).
A two-dimensional NOESY spectrum [31] (75 ms) was recorded with 440
increments (64 scans each) in t1 and 2K complex points in t2 time domain using
a spectral width of 8500 Hz in both dimensions with the 1H carrier on water. The
water signal was suppressed by WATERGATE [32]. A natural abundance
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each) in the indirect dimension. The carrier was placed at water resonance
(4.7 ppm) in the proton dimension (spectral width 8500 Hz) and at 118.2 ppm in
the nitrogen dimension (spectral width 2200 Hz). A natural abundance HSQC
spectrum correlating aromatic 13C (spectral width 3000 Hz, 30 increments) and
1H (spectral width 8500 Hz) was also collected. Data were recorded on a Varian
INOVA 600 MHz NMR spectrometer equipped with a triple-resonance
cryogenic probe with a z-axis gradient capability.
NMR data were processed on a Silicon Graphics Octane workstation (SGI)
using the NMRPipe software [34]. For NOESY, the time domain data were
apodized by a 63° shifted squared sine-bell window function in both
dimensions, zero-filled prior to Fourier transformation. For HSQC, the data in
the indirect dimension were doubled by linear prediction prior to Fourier
transformation. Since anionic DSS is known to interact with cationic peptides
[27], proton chemical shifts of the peptides were referenced to external DSS at
0.00 ppm. NMR data were analyzed with NMRDraw in the NMRPipe package
[34] and PIPP [35].
2.3. Structure calculations
The three-dimensional structure of pepA bound to the D8PG micelle at pH
5.4 and 30 °C was calculated based on both distance and angle restraints byFig. 1. NMR spectra of pepA in complex with D8PG at pH 5.4 and 30 °C.
Shown are (a) the fingerprint region of the NOESY spectrum (mixing time
75 ms) and (b) natural abundance HSQC spectrum of the peptide. In (a), the
position of each residue in the spectrum is labeled. Inter-residue NOE cross
peaks are labeled with Arabic numbers. For example, 23/26 stands for an NOE
between the Hα proton of residue 23 and the amide backbone proton of residue
26. In (b), signals from the C-terminal amidation and the side chains of Q22 and
N30 are connected by lines. Arginine side chain signals are boxed.
Fig. 2. Chemical shift plots of pepA and pepB. (a) The Hα secondary shift plot of
pepA inD8PG. Secondary shifts were calculated by taking the differences between
the measured chemical shifts for the peptide and those random-coil values [37].
(b) The Hα chemical shifts of pepA measured in SDS (peptide/SDS ratio 1:40,
25 °C, pH 5.4, red line) and D8PG (peptide/D8PG 1:5, pH 5.4, 30 °C, blue line).
(c) The Hα chemical shifts of pepB measured in SDS (peptide/SDS ratio 1:40,
pH 5.4, 25 °C, green line) and D8PG (peptide/D8PG 1:5, pH 5.7, 25 °C, red line).using the simulated annealing protocol in Xplor-NIH [36]. The distance
restraints were obtained by classifying the NOE cross-peak volumes into strong
(1.8–2.8 Å), medium (1.8–3.8 Å), weak (1.8–5.0 Å), and very weak (1.8–
6.0 Å) ranges. The distances were calibrated on the basis of the typical NOE
patterns in an α helix [37]. For each residue in the helical region predicted based
on 1Hα and 15N chemical shifts, the backbone ϕ and ψ angles as predicted by
TALOS [38] were applied (see Results for justification). A broader range than
predicted (±20°) was allowed for each angle in structural calculations. A
covalent peptide structure with random ϕ, ψ, and χ angles but trans planar
peptide bonds was used as a starting structure. The peptide structural templates
were also amidated at the C-terminus using X-PLOR [39]. In total, 100
structures were calculated and an ensemble of 20 structures with the lowest total
energy was chosen for structural analysis. This final ensemble of accepted
structures also satisfies the following criteria: no NOE violations greater than
0.50 Å, rmsd for bond deviations from ideality less than 0.01 Å, and rmsd for
angle deviations from ideality less than 5°. Structures were viewed and analyzed
by MOLMOL and PROCHECK [40,57].
2.4. Peptide–lipid interactions
The formation of the peptide–lipid complex led to direct contacts between
the peptide and D8PG. When pairs of peptide–lipid protons are within 5 Å, they
offer extra relaxation pathways in addition to those within the peptide proton
network. When deuterated detergents such as SDS or DPC are utilized, the
peptide–detergent cross relaxation pathways are blocked. Such relaxation
pathways, however, are in action when protonated lipids or detergents are
utilized [41]. Intermolecular NOE cross peaks can be identified by comparing
the spectrum with that recorded in the corresponding deuterated micelle. In this
study, one-dimensional slices were taken from the NOESY spectra at well
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peaks from D8PG to each peptide resonance.
3. Results
3.1. Solution structure of pepA in complex with D8PG
The peptide signals are well dispersed in the two-dimensional
NOESY spectrum (Fig. 1a). Since TOCSY and DQF-COSY
spectra are not very useful in the presence of an excess amount of
protonated lipid, we utilized natural abundance HSQC spectra to
locate the positions of backbone and side chain amide protons
(Fig. 1b) as well as aromatic protons of pepA (not shown).
Sequential assignments were then achieved by using NOESY
[37]. To predict the secondary structure of pepA, we calculated
Hα secondary shifts [58] based on the assignments as well as the
random-coil chemical shifts tabulated byWüthich [37]. A plot of
pepA secondary shifts versus residue number is provided in
Fig. 2a. Except G13, the rest of the residues have negative
secondary shifts less than −0.1, indicating a helical structure for
nearly the entire peptide [58]. Indeed, the helicity of the peptide
was estimated to be 98% based on the average Hα secondary
shift divided by 0.38. As a comparison, we also obtained the
chemical shifts of pepA in complex with deuterated SDS (SDS/
peptide ratio=40) at pH 5.4 and 25 °C. A superimposed view of
the Hα chemical shifts of pepA in SDS and D8PG is provided in
Fig. 1b. The majority of the shifts are very similar, except for the
N-terminus of the peptide. A quantification of the helicity of
pepA in SDS based on secondary shifts revealed 86% helix,
indicating a less helical structure in SDS than in D8PG. To
provide further support for the helical structure, Fig. 3a presentsFig. 3. Intramolecular (a) and intermolecular (b) NOE connectivities for pepA bound
the hydrophobic, hydrophilic, and interfacial surface are in green, black, and red, resp
of the lines. The thicker the lines, the stronger the NOE cross peaks. Here α=Hα, β=H
of the peptide–lipid NOE cross peaks in Fig. 5 are indicated by the darkness of the sq
is similar to that described for C3–C7 protons of D8PG (Fig. 5b), although weaker. I
intensity, identity, or both. For the peptide, BB=backbone and SC=side chain. Forthe NOE connectivity diagram for pepA in complex with D8PG.
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α
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cross peaks indicates an α-helical structure covering residues
14–31. The three-dimensional structure of pepA bound to D8PG
was calculated based on 182 NOE-derived distance restrains and
34 backbone angle restraints. Note that in our original approach
[25], natural abundance heteronuclear chemical shifts 1Hα,
13Cα, 13Cβ, and 15N measured for the peptides bound to
perdeuteratedmicelles were used in the TALOS [38] predictions.
Here only 1Hα and 15N chemical shifts were obtained, because
protonated D8PG in the peptide sample made the measurements
of natural abundance 13C chemical shifts difficult. To justify the
use of 1Hα and 15N for angle prediction, we compared the results
predicted by TALOS using different combinations of the chemi-
cal shift data of pepA in deuterated SDS. Three combinations
were tested: (1) 1Hα, 13Cα, 13Cβ, and 15N; (2) 1Hα and 15N; and
(3) 1Hα only. Interestingly, the predicted backbone ϕ and ψ
angles are actually very similar for residues 15–31 of pepA and
differ within six degrees. Thus, the 1Hα and 15N generated
backbone angles are applicable to structure refinement at least in
this particular case. An ensemble of 20 backbone structures is
presented in Fig. 4a. The rmsd is 0.48 Å when the backbone
atoms of residues 14–29 of the peptide are superimposed. In
nearly all structures, residues 14–29 of pepA are helical and 94%
of the residues are located in the most favored region of the
Ramachandran plot according to PROCHECK analysis [57]. A
detailed structural statistics is given in Table 2. Since hydrophilic
side chains (K15, K18, R19, Q22, D26, and R29) are located on
one side of the structure (top) and hydrophobic side chains (I14,
F17, I20, V21, I24, F27, L28, and L31) on the other (bottom), theto D8PG at a peptide/D8PG molar ratio of 1:5, pH 5.4 and 30 °C. Side chains on
ectively (cf. Fig. 4b). In panel a, NOE intensities are represented by the thickness
β, and HN stands for backbone amide protons. In panel b, the relative intensities
uares. The NOE pattern to the C2-H of D8PG (Fig. 5c) was not presented since it
n both panels, question marks suggest peak overlap, causing uncertainty in peak
an illustration of lipid protons, see Fig. 5a.
Table 2
Structural Statistics for PepA Bound to D8PG
NOE restraints
Intra-residue 75
Sequential 63
Short range 44
Total 182
Backbone angles (ϕ and ψ) a 34
RMSD for superimposing residues 14–29 b
Backbone atoms 0.48 Å
Heavy atoms 1.32 Å
All atoms 1.63 Å
Ramachandran plot c
Residues in the most favored region 94.4%
Residues in the additional allowed region 5.6%
a Predicted by TALOS [38].
b Calculated by MOLMOL [40].
c Calcualted by Procheck [57].
Fig. 4. Solution structure of pepA determined in dioctanoyl phosphatidylglycerol. (a) An ensemble of 20 backbone structures with residues 14–29 superimposed. (b) A
ribbon representation of the peptide structure with side chains labeled. (c) Potential surface of the peptide with the hydrophobic surface facing the readers. (d) Potential
surface of the peptide with the hydrophilic surface facing the readers. Color code: acidic residues in red, basic residues in blue, and hydrophobic chains in white.
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chains, including E16, R23, K25, and N30 are located in the
interface between the hydrophobic and hydrophilic surfaces
(Fig. 4, panels b and c). Such an amphipathic helix, rich in
positively charged side chains (Fig. 4d, blue), is attractive to
negatively charged bacterial membranes.
3.2. Intermolecular NOE cross peaks between pepA and D8PG
To obtain direct evidence for the peptide–lipid interactions,
we also analyzed the intermolecular NOE cross peaks between
the peptide (Fig. 4b) and D8PG (Fig. 5a) in the same NOESY
spectrum. Because proteins and lipids differ in chemical
structure, they also possess unique chemical shifts. Previously,
we found that the aromatic side chain of phenylalanine or its
analog phenylglycine is a useful probe for peptide–lipid inter-
actions [23]. We demonstrate here that there are intermolecular
NOE cross peaks covering the entire antimicrobial peptide,
allowing a detailed mapping of the peptide location on a PG
micelle by solution NMR. Fig. 5b–d shows several one-
dimensional slices taken in the 2D spectral regions cor-
responding to lipid signals at 1.23 ppm (C3–C7 H), 2.34 ppm
(C2-H), and 5.25 ppm (Hβ) (Fig. 5a). These lipid signals
possess unique chemical shifts and do not overlap with the
peptide signals under investigation. Therefore, along each lipid
1D slice, a cross peak at a frequency corresponding to the
peptide resonance results from through-space proton–proton
cross relaxation between the peptide and lipid. Since cross
relaxation rates are inversely proportional to r6, where r is the
distance between the protons, the existence of such cross peaks
at a relatively short mixing time (75 ms) indicates that the pairsof protons are within 5–6 Å. In current solution NMR practice,
NOE cross peaks are classified into different groups and the
NOE volumes are converted to upper bounds (e.g., 2.5, 3.5, 5
and 6 Å for strong, medium, weak, and very weak peaks,
respectively) [37]. The strongest peaks in Fig. 5b result from the
interactions between the C3–C7 protons of D8PG and the
aromatic side-chains of F17 and F27 of the peptide. The inten-
sities of such intermolecular NOE cross peaks involving aro-
matic protons are decreasing from C3 to C7 protons (Fig. 5b), to
C2 protons (Fig. 5c), to the glycerol backbone Cβ proton
(Fig. 5d). The peak intensities of the aromatic protons of F17
and F27 to the acyl chain of D8PG are comparable to intra-
peptide NOE cross peaks of medium intensity, indicative of a
Fig. 5. Intermolecular peptide–lipid nuclear Overhauser effects allow the depiction of a model for the membrane peptide–D8PG interactions. (a) The structure of
D8PG. (b–d) One-dimensional slices taken at 1.24, 2.34, and 5.25 ppm (well-resolved lipid signals) of the indirect dimension of the 2D NOESY spectrum collected
under the identical conditions as described for Fig. 1a. In this view, peak heights in both panels c and d have been amplified twice, while the peak height in panel b has
been scaled by 50%. (e) A peptide–membrane interaction model derived from intermolecular NOE data. The peptide and lipid may not be exactly to the scale.
However, the surface location of pepA derived from solution NMR is consistent with solid-state NMR data of LL-37 bound to the lipid bilayer model [52,56].
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weak NOE cross peaks from the aromatic protons to the
glycerol backbone Cβ proton indicates a distance of ∼5 Å.
There are also weak NOE cross peaks (∼5 Å separation)
from the lipid C2 and C3–C7 protons (i.e., lipid acyl chain) to
the backbone amide protons of hydrophobic residues of the
peptide such as I14, I24, and L28 (labeled above the baseline in
Fig. 5b). The NOE cross peaks to residues I20, V21, I24, and
L28 in the middle of the helix are slightly stronger than those at
both ends (i.e., I14, L31, and V32), suggesting that the middle
region is closer to lipids and probably more important for
binding.
A further examination reveals that the cross peaks from the
lipid acyl chain to the backbone amides of hydrophilic residues
(labeled underneath the baseline) are even weaker or invisible
(cf. V14 vs. K15 or R19 vs. I20 in Fig. 5b), suggesting that they
are farther away from the lipid. Furthermore, no NOE cross
peaks were detected from D8PG to the hydrophilic side chainsof Q22, N30 (dotted lines in Fig. 5b–d), R19, or R29 (arrowed
lines in Fig. 5b), consistent with the picture that they are even
farther away from the lipid (Fig. 5e). R23 is an exception,
however. Its hydrophilic side chain HN proton shows an NOE
cross peak with Hβ, C2-H, and C3–C7 protons of D8PG and
the intensity of the peak in Fig. 5b is comparable to those with
the hydrophilic backbone amide protons of R19 and R29
(Fig. 4b). Such intermolecular NOE cross peaks suggest that the
R23 side chain of pepA is closer to the lipid than other arginine
side chains of pepA. A summary of such intermolecular NOE
cross peaks is provided in Fig. 3b. Clearly, such an inter-
molecular NOE pattern is perfectly consistent with the three-
dimensional structure of the peptide (Fig. 4b) determined in the
same lipid using the same NOESY spectrum (Fig. 1a). While
the side chain of R23 is indeed located in the hydrophobic/
hydrophilic interface of the amphipathic helix at a height similar
to the hydrophilic peptide backbone, the side chains of both R19
and R29 are located on the hydrophilic face (Fig. 4b). Such side
3277G. Wang / Biochimica et Biophysica Acta 1768 (2007) 3271–3281chain locations were not derived from one structure but from the
structural ensemble (Fig. 4a).
Taken together, the 3D structure and the peptide–lipid NOE
cross peaks enable us to depict a model for peptide–membrane
interactions (Fig. 5e). In this model, part of the lipid molecules
in the micelles are displaced by the hydrophobic portion of the
peptide, which is located on the surface of the lipid micelles,
where the hydrophobic peptide side chains are in direct contact
with lipid acyl chains (∼3.5 Å due to medium NOEs in Fig. 5b)Fig. 6. The interactions of a non-helical peptide (pepB) with D8PG. (a) Structure of p
and 2.29 ppm from the 2D NOESY spectrum as indicated by arrows in panel d. The in
mixing time for the cross peak between Hδ protons of F17 and the C2-H of D8PG. (d
with D8PG at a peptide/lipid molar ratio of 1:5, pH 5.7 and 25 °C.and are approximately 5 Å from the glycerol backbone Hβ
proton (due to weak NOEs in Fig. 5d). The increase in NOE
intensity, from hydrophilic side chains, hydrophilic backbones,
hydrophobic backbones, to hydrophobic side chains, is
indicated by the darkness of the box in Fig. 3b. Such a trend
applies to both the N-terminal (from R19 to F17) and C-terminal
(from R29 to F27) portions of the peptide, indicating a similar
surface location of the entire amphipathic helix in the lipid
micelle. To our knowledge, this is the first detailed picture thatepB bound to SDS micelles [22]. (b and c) One-dimensional slices taken at 1.27
sert in panel b shows the intermolecular NOE buildup curve with the increase of
) A portion of the NOESY spectrum (mixing time 100 ms) of pepB in complex
3278 G. Wang / Biochimica et Biophysica Acta 1768 (2007) 3271–3281delineates the interaction of a cationic antimicrobial peptide
with the D8PG lipid at the atomic level.
3.3. Intermolecular NOE cross peaks between pepB and D8PG
To further understand peptide–lipid interactions, we also
examined intermolecular NOE cross peaks between a non-
helical peptide (pepB) and D8PG. The sequence of this peptide
corresponds to residues 17–32 of LL-37 with residues 20, 24,
and 28 changed into D-amino acids (Table 1). This peptide was
found previously to be capable of killing bacteria without a
cytotoxic effect on human cells. The structure of pepB bound to
deuterated SDS was previously elucidated [22]. Due to the
distortion of the peptide backbone by D-amino acids, pepB
adopts a novel amphipathic structure with multiple turns
(Fig. 6a). According to the near identical Hα chemical shifts in
the two micelles (Fig. 2c), pepB appears to have a very similar
backbone structure in SDS and D8PG. The NOESY spectrum of
pepB in D8PG is presented in Fig. 6. The intermolecular NOE
slices were taken along 1.27 and 2.29 ppm (Fig. 6, panels b
and c). Like pepA, the aromatic rings of F17 and F27 of pepB
also showed intense intermolecular NOE cross peaks with
D8PG, indicating a micelle-anchoring role of these rigid
hydrophobic rings of the peptides. The variation of the intensity
of the NOE cross peak between Hδ protons of F17 of pepB and
the C2-H protons of D8PG with the mixing time is provided as
an insert in Fig. 6b. As expected, a normal NOE buildup
indicates that such intermolecular NOE cross peaks result from
direct dipolar interactions rather than spin diffusions [37]. There
are also peptide–lipid NOE cross peaks from the backbone
amides to the acyl chains of D8PG. However, intermolecular
NOE intensities are more or less comparable for hydrophobic
(e.g. I24, L28, and L31) and hydrophilic (e.g. K25 and R29) side
chains. Furthermore, the εHN side-chain protons of all arginines
also display NOE cross peaks with D8PG of similar intensities.
Clearly, such an overall intermolecular NOE pattern observed
for pepB (Fig. 6) differs from that observed for pepA (Fig. 5).
This is because pepA and pepB adopt different structures, which
may interact with membranes in different manners. For pepA,
there is a coherent and powerful hydrophobic surface for micelle
binding and not all cationic side chains are involved. In the case
of pepB, however, the incorporation of D-amino acids reduced
the hydrophobicity of the peptide as previously measured by
reverse-phase HPLC [22]. Thus, it may be necessary that the
cationic side chains of pepB are contributing to lipid binding so
as to compensate for the loss in peptide hydrophobicity. Con-
sidering that pepB is active against Gram-negative bacteria such
as E. coli (rich in PGs in cellular membranes) but is non-toxic to
human cells (rich in phosphocholines in cellular membranes)
[22], the enhanced binding capability of pepB to bacterial
membranes may result primarily from electrostatic interactions of
those positively charged arginines with negatively charged PGs.
4. Discussion
Structures of antimicrobial peptides are usually elucidated by
solution NMR using SDS and/or DPC micelles as membrane-mimetic models [6,10]. Since cationic peptides are known to
prefer anionic lipids, my lab has explored the use of PGs
with lipid chain length ranging from six to ten [27–29]. We
previously proposed a combined use of deuterated SDS and
protonated PGs for optimal structural determination and
intermolecular NOE observation. A potential caveat of that
practice is that the peptide might adopt slightly different struc-
tures in the two micelles. Therefore, it will be ideal to measure
everything on the same sample. We demonstrate here that both
structure and micelle location of pepA can be determined in
D8PG by using the same NOESY experiment. This practice is
necessary since the quality of both TOCSY and DQF-COSY
spectra became very poor in the presence of an excess amount
of protonated lipids [10]. The signal assignments were
facilitated by comparison with the NOESY spectrum recorded
previously for a similar peptide in deuterated SDS micelles [22].
Compared to the structure of the C-terminal fragment of LL-37
in SDS, where residues 17–30 are helical, pepA has a longer
helix covering residues 14–29. The extension of the helical
structure at the N-terminus of pepA may be due to both the use
of a different micelle (SDS vs. D8PG) and the sequence differ-
ence (see Introduction). To narrow down the possibilities, the
chemical shifts of pepA in SDS were compared with those in
D8PG. Fig. 2b supports the notion that pepA is less helical in
SDS than in D8PG. This plot differs from the chemical shift
plots of several shorter membrane peptides investigated
previously, including the bacterial membrane anchor [27], an
aurein 1.2 analog [25], the minimal antibacterial region of
human LL-37 [22], and pepB in Fig. 2c. The nearly identical Hα
chemical shifts for those peptides in SDS and D8PG indicate
similar structures and enabled the use of perdeuterated SDS for
structure determination at higher quality [23]. Thus, peptide A
provides the first documented case where subtle structural
differences were observed for a membrane peptide in SDS
(helicity 86%) and D8PG (98%). This finding underscores the
importance of structural studies of membrane peptides and
proteins in a proper membrane-mimetic environment. Indeed,
some membrane proteins such as bacterial potassium channel
KcsA only function properly in the presence of PGs rather than
detergents such as SDS [59]. As a consequence, caution should
be taken to avoid potential structural artifacts from the use of
SDS or other artificial membrane-mimetic agents.
The surface binding of pepA, an LL-37-derived peptide,
agrees with the finding from previous solid-state NMR studies
in lipid bilayer [42,56]. Our study, however, provides detailed
information for peptide–lipid interactions as a consequence of
slice analysis (Figs. 5 and 6). The aromatic side chains of
phenylalanines are very useful probes [23], giving the strongest
intermolecular NOE peaks in the slices. It is interesting to note
that the NOE cross peaks involving backbone amide protons of
hydrophobic residues are slightly stronger than those from
hydrophilic residues of pepA. Such an intermolecular NOE
pattern agrees nicely with the amphipathic structure that the
hydrophobic face of the peptide is in direct contact with the lipid
micelle. Remarkably, there are also differences in the inter-
molecular NOE cross peaks involving cationic side chains. In
the case of pepA, only R23 in the interface showed a clear NOE
3279G. Wang / Biochimica et Biophysica Acta 1768 (2007) 3271–3281with D8PG, fully consistent with the structure, where R19 and
R29 are located on the hydrophilic face (Fig. 4b). In the case of
pepB, the three arginine side chains showed similar intermo-
lecular NOE cross peaks, presumably enhancing peptide's
interaction with anionic lipids. The differences in peptide–
membrane interactions observed here shed light on the activity
data measured previously [22]. While LL-37 and its C-terminal
fragment or the minimal antibacterial region showed toxicity to
both bacteria and human cells, pepB is toxic only to bacteria but
not to human cells. Since pepA is a close mimic of LL-37 and its
sequence includes the minimal LL-37 peptide, it is reasonable to
predict that pepA is also toxic to human cells. All these LL-37-
derived peptides form amphipathic helical structures and are
much more hydrophobic than pepB (see Table 1 of ref. [22]).
The coherent hydrophobic surface of pepA is sufficiently
powerful to allow it to associate with human cells rich in
zwitterionic lipids. In contrast, the poor hydrophobicity of pepB
made it deficient in binding to human cell membranes. Of note
is that the bacterial membrane anchor was found to have a
minimal membrane-targeting ability that determines its sole
binding to bacterial membrane but not to vesicles consisting of
zwitterionic phosphocholines [26]. Remarkably, pepB and the
bacterial membrane anchor have nearly identical retention times
on the reverse-phase HPLC [22]. When these peptides interact
with bacterial membranes rich in anionic PGs, additional elec-
trostatic interactions between the peptide cationic side chains
and anionic PGs further enhance their membrane binding. This
added power by several cationic side chains as observed here by
intermolecular NOESY (Fig. 6) enabled the binding of pepB
to bacterial membranes and explains its selective membrane
targeting.
As this issue of the journal is dedicated to NMR studies of
membrane proteins, it is useful to highlight the major solution
NMR experiments designed to extract protein–lipid NOE
information. The first and simplest experiment is 2D NOESY.
In the presence of a protonated lipid, the NOESY spectra
contain both intra-peptide and peptide–lipid NOE cross peaks.
In this case, usually partial information is extracted by focusing
solely on well-resolved resonances such as Tyr, Trp, Phe, Met,
His, and Arg side chains [23,25,27,43–48]. When spectral
resolution allows, we found previously that two aromatic
phenylalanines showed different intermolecular NOE patterns,
implying different penetration depths into the micelle [23]. Slice
analysis as illustrated here (Fig. 5b–d), however, enables a
detailed description of peptide–membrane interactions
(Fig. 5e). Intermolecular NOE cross peaks can also be obtained
from 3D heteronuclear-edited NOESY spectra. For example,
Wüthrich and colleagues [49] detected intermolecular NOE
cross peaks from the backbone amide protons outside of the
OmpX beta-barrel to dihexanoyl phosphatidylcholine (DHPC),
verifying the transmembrane nature of the protein. Another
approach is to use filtered experiments [50] developed for
observing intermolecular NOE cross peaks between protein–
ligand complexes. Such intermolecular NOE cross peaks form
the basis for structural determination of protein–ligand com-
plexes, including protein–protein and protein–DNA com-
plexes. To perform this experiment, one component in thecomplex should be isotopically labeled, allowing the selection
of the magnetization from labeled molecules to unlabeled
molecules. One such example is provided in ref. [50]. Finally,
protein–detergent interactions can be examined by selectively
irradiating detergent signals followed by detecting the NOE
perturbations on the protein, allowing for a quantitative
evaluation of cross relaxation between the potassium channel
and SDS [51]. Regardless of the particular type of NMR
experiments, the above intermolecular NOE information
unambiguously established that membrane proteins or peptides
are indeed located in membrane-mimetic micelles, by either
attaching to the membrane surface or going through the mem-
brane. As with the structural determination of protein–protein
complexes, it is anticipated that such protein–lipid intermolec-
ular NOE cross peaks are useful restraints for structural deter-
mination of the entire protein–membrane complexes.
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